Organisation paid for research Program year 2024 Source: CMS Open Payments

Crimson Pain Management, LLC

Neither a doctor nor a teaching hospital

Research payments

$32,681

14 payments

Through program year 2024, Crimson Pain Management, LLC is reported as receiving $32,681 in research payments, across 14 payments.

By program year

4 rows
Year Kind Amount Payments
2024 Research $6,301 4
2023 Research $4,065 1
2022 Research $15,765 7
2021 Research $6,550 2

Breakdown

Who paid Research payments · program years 2021–2024
  1. Nevro Corp. $32,681 14 payments
Studies the money was for Research payments · program years 2021–2024
  1. Post-Market Multicenter Study Prospective $6,550 2 payments
  2. Recharge II $6,301 4 payments
  3. Ca2022-1 US Recharge II $5,500 1 payment
  4. Ca20221usrechargeii $4,065 1 payment
  5. Post-Market Multicenter Study Prospective $3,725 1 payment
  6. Post-Market Multicenter Study Prospective $2,050 1 payment
  7. Post-Market Multicenter Study Prospective $1,325 1 payment
  8. Ca2018-2 Senza US Nsrbp $1,315 1 payment
  9. Ca2018-2 Senza US Nsrbp $1,000 1 payment
  10. Ca2018-2 Senza US Nsrbp $850 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record